Telestroke Services Market Size to More Than Double by 2028

The global telestroke services market is primed for considerable growth this decade, due to rising stroke caseloads, increasing numbers of patients suffering from cardiac disorders, and new product innovation. 

The Insight Partners forecasts the sector to expand from $1.54 billion in value this year to $4.67 billion by 2028, swelling 20.2% annually over the next six years. Stroke unawareness, however, could hinder the market’s growth.

Stroke is one of the leading causes of death and disability worldwide, and a top public health concern with serious economic and social consequences. The public health burden of stroke will increase in the coming decades due to changing demographics, particularly in developing countries. With the development of new treatment modalities, including the use of intravenous tissue plasminogen activator and mechanical thrombectomy, clinical outcomes in patients with acute ischemic stroke have improved. However, these interventions are time-sensitive, and there are major disparities between rural and urban regions in terms of the availability of neurologists and life-saving treatment options. Risk of death and poor prognosis after stroke increase with delays in diagnosis and treatment. Further, there is a growing shortage of neurologists, particularly in underserved rural areas. According to Frontiers Media S.A., this supply gap of neurologists is projected to increase from 11% in 2012 to roughly 19% by 2025, with the largest decline in the number of vascular neurologists. Moreover, strokes can be divided into two main categories—ischemic stroke and hemorrhagic stroke. Ischemic stroke is caused by the cutting off of blood supply to a part of the brain, resulting in a sudden loss of function, while hemorrhagic stroke is due to a rupture of a blood vessel or an abnormal vascular structure.

Stroke continues to be a major health concern despite advances in understanding several factors regarding the disease, such as epidemiology, quality of life, and pathophysiology. According to the Indian Stroke Association, the incidence of stroke in India has increased by about 100% over the past few decades. Furthermore, approximately 1.8 million people in India suffer a stroke yearly, and only early treatment can reduce morbidity and mortality. Further, even though the growing incidence of noncommunicable diseases such as stroke threatens the larger population, stroke treatment and rehabilitation remain underdeveloped in the country. As per the American Heart Association, about one in 19 U.S. deaths in 2018 was due to a stroke, and in 2016, on average, one person died from a stroke every three minutes, 33 seconds. Further, stroke is the fifth-highest cause of death in the United States, resulting in 147,810 deaths in 2018. Overall, there were an estimated 460,000 strokes in the United States in 2019 (two-thirds were ischemic), 190,000 were stroke-related deaths, and 3.83 million stroke-disability-adjusted life years. Therefore, owing to the rising number of stroke cases across the globe is expected to boost the telestroke services market.
 
The ischemic segment holds a larger share in the telestroke services market in 2022; moreover, it is expected to register a higher annual from 2022 to 2028.
 
Based on end user, the telestroke services market is segmented into telehospitals/teleclinics, telehome, and others. The telehospitals/teleclincs segment holds the largest share in 2022 and is anticipated to continue to be the largest shareholder by 2028.

Asia Pacific is expected to witness the highest growth in the telestroke services market, and China holds the largest share of the regional market, followed by Japan. The telestroke services market growth in China is ascribed to the increase in noncommunicable diseases such as cardiovascular disorders and diabetes, which has contributed to the rising prevalence of stroke cases. According to the Chronic and Noncommunicable Disease Prevention and Control Center of the Chinese Center for Disease and Prevention, roughly 33% of adults received diagnoses of hypertension, and approximately 9.5% had diabetes.